Description
Composition
Each milliliter (mL) of Glarin SC Injection Solution contains 100 units (equivalent to 3.64 mg) of insulin glargine. The product is available in cartridges, each containing 3 mL of the solution, totaling 300 units (equivalent to 10.92 mg) of insulin glargine. This biosimilar insulin is produced using recombinant DNA technology with Escherichia coli.
Packaging
Glarin SC Injection Solution is available in packages containing five cartridges, each holding 3 mL of the solution.
Usage
Glarin SC Injection Solution is intended for subcutaneous injection. It should be administered once daily, at the same time each day. The dosage and timing should be tailored to the individual’s needs as prescribed by a healthcare professional.
Glarin Sc Kullanim Precautions
Before Using
- Do not use Glarin if you are allergic to insulin glargine or any excipients in the formulation.
- Avoid injecting cold insulin to prevent pain.
- Do not shake the container to avoid damaging the insulin.
- Inspect the product for particles, thickening, or clumps and discard if any are present.
- Do not use Glarin during episodes of hypoglycemia or diabetic ketoacidosis.
During Treatment
- Follow all instructions for the proper use, injection, and storage of the insulin.
- Measure each dose carefully and use exactly as prescribed by your doctor.
- Rotate injection sites with each dose to reduce the risk of lipodystrophy and cutaneous amyloidosis.
- Do not share an injection pen, even if you have changed the needle.
Special Considerations
- The safety and effectiveness of Glarin have not been established in patients under two years of age or those with liver or severe kidney insufficiency.
- Always consult your healthcare provider with any questions or concerns.
Special Populations
Due to limited experience, Glarin’s safety and efficacy have not been evaluated in patients under two years of age, those with liver insufficiency, or those with moderate to severe kidney insufficiency.
Generic Versions
Generic versions of Glarin SC Injection Solution are available, such as Lantus and Toujeo. These contain the same active ingredient, insulin glargine, but may differ in dosage form, strength, route of administration, and other characteristics. Consult your healthcare provider before switching to a generic version.
Benefits
Effective Blood Sugar Control
Glarin SC Injection Solution effectively lowers high blood sugar in adults, adolescents, and children over two years old. Insulin glargine is similar to human insulin and offers a long-lasting and stable blood sugar-lowering effect.
Long-Lasting Effect
Insulin glargine provides a prolonged action, helping to maintain stable blood sugar levels throughout the day, crucial for effective diabetes management.
Easy to Use
Glarin comes as a clear, colorless injectable solution intended for subcutaneous administration, making it convenient for at-home use without needing a healthcare professional.
Versatile
Suitable for adults, adolescents, and children over two years old, Glarin offers a versatile option for diabetes management across different age groups.
Storage Guidelines
General Storage
- Store unopened containers in a refrigerator.
- Do not freeze. Discard if frozen.
- Be aware of how long unopened containers can be stored at room temperature before needing disposal.
Precautions
- Always check the expiry date before use.
- Discard if there are any signs of deterioration.
- Keep out of reach of children.
Handling Missed Doses
General Guidelines
- Take the missed dose as soon as possible.
- Skip the missed dose if it is almost time for the next one.
- Never double up doses to make up for a missed one.
Precautions
- Monitor blood sugar levels closely after missing a dose.
- Consult your healthcare provider for guidance if unsure about what to do after a missed dose.
Onset of Action
Insulin glargine, the active ingredient in Glarin SC Injection Solution, has a long and stable effect on lowering blood sugar. It generally begins to work several hours after injection and continues to work evenly for 24 hours. Individual responses may vary based on dosage, injection site, blood supply, temperature, and physical activity.
Table: Glarin SC Injection Solution Information
| Category | Details |
|---|---|
| Active Ingredient | Insulin glargine |
| Composition | 100 U/mL (equivalent to 3.64 mg) per mL; 300 U (equivalent to 10.92 mg) per 3 mL cartridge |
| Packaging | 5 cartridges per package, each with 3 mL solution |
| Usage | Subcutaneous injection, once daily at the same time |
| Precautions | Allergic reactions, hypoglycemia, proper storage, and handling instructions |
| Special Populations | Not evaluated for under 2 years, liver insufficiency, severe kidney insufficiency |
| Generic Versions | Lantus, Toujeo |
| Benefits | Effective blood sugar control, long-lasting effect, ease of use, versatile for various ages |
| Storage Guidelines | Refrigerate unopened containers, do not freeze, check expiry date |
| Missed Doses | Take as soon as possible, skip if close to next dose, do not double doses |
| Onset of Action | Several hours post-injection, stable effect for 24 hours |
Conclusion
In conclusion, Glarin SC Injection Solution is a vital medication for managing diabetes mellitus in a wide range of patients. Its long-lasting effect, ease of use, and versatility make it a reliable option for maintaining stable blood sugar levels. Always follow the prescribed guidelines and consult healthcare providers for personalized advice.
Reviews
There are no reviews yet.